Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03834493
Brief Title: Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)

First Submitted : February 6, 2019
First Submitted that Met QC Criteria : February 6, 2019
First Posted : February 8, 2019

Last Update Submitted that Met QC Criteria : June 17, 2021
Last Update Posted : June 18, 2021